CClinicalTrials.gg
CompletedNCT02733757Updated Aug 25, 2020Results posted

Clonidine Added Lidocaine in Intraocular Pressure and Hemodynamics Ocular in Sub-Tenon's and Peribulbar Anesthesia

A Phase 2 interventional study of Clonidine in Anesthesia, sponsored by Federal University of Minas Gerais. Completed. Open to participants aged 30 Years to 86 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-08-25.

Sponsored by Federal University of Minas Gerais · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
30 Years to 86 Years
Sex
All
01

Study summary

Regional anesthesia in orbit can reduce ocular blood flow, increase in intraocular pressure (IOP) or the pharmacological action of local anesthetics. This study was conduced to evaluate the effects of clonidine added to lidocaine in IOP, ocular perfusion pressure (PPO) and ocular pulse amplitude (OPA) in patients undergoing cataract surgery under sub-Tenon's and peribulbar anesthesia.

Read the detailed description

In this prospective randomized and double blind clinical study, involving 80 patients with ages from 30 to 86 years old, ASA I and II, both genders. The patients were randomly divided into 4 groups of 20 patients, and then were administered in control sub-Tenon's group 5 mL of 2% lidocaine with 1 mL of 0.9% sodium chloride solution; in sub-Tenon's group clonidine, 5 mL of 2% lidocaine associated with 1 µg/kg of clonidine diluted in 1 mL 0.9% sodium chloride solution. In the peribulbar anesthesia, the control group with 6 mL of 2% lidocaine and 1 mL of 0.9% sodium chloride solution, and peribulbar group clonidine, 6 mL of 2% lidocaine associated with 1 µg/kg of clonidine diluted in 1 mL 0.9% sodium chloride solution. Were evaluated the systemic hemodynamic variables; IOP and OPA measurements according the dynamic contour tonometer (DCT) and calculation of OPP, prior to the blockade (M0), and one (M1), five (5) and ten minutes (M10) after the injection of the anesthetic solutions. Complications related to the sub-Tenon's and peribulbar anesthesia were recorded.

02

Conditions studied

  • Anesthesia

Keywords

  • Clonidine
  • Sub-Tenon's and Peribulbar block
  • IOP
  • OPP
  • OPA
03

In context

Lead sponsor

Federal University of Minas Gerais is the lead sponsor of 150 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 86 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adults between 30 and 86 years old
  • Both genders
  • Physical status ASA (American Society of Anesthesiologists) I and II
  • Cooperative patients undergoing cataract surgery by phacoemulsification

Exclusion criteria

Exclusion Criteria:

  • Patients with communication difficulties
  • Allergic to any medication protocol
  • Chronic therapy with clonidine
  • In use of antihypertensive medication
  • Diabetes
  • Glaucoma
  • Previous surgery in the same eye
  • Abnormalities in coagulation
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
80 participants (actual)

Study arms

  • No intervention
    Sub-Tenon's group control

    2% Lidocaine without epinephrine

  • Experimental
    Sub-Tenon's group clonidine

    2% Lidocaine without epinephrine plus clonidine 1 µg/kg

    Drug: Clonidine

  • No intervention
    Peribulbar group control

    2% Lidocaine without epinephrine

  • Experimental
    Peribulbar group clonidine

    2% Lidocaine without epinephrine plus clonidine 1 µg/kg

    Drug: Clonidine

Interventions

  • DrugClonidine

    Clonidine 1 µg/kg plus 2% lidocaine

    Also known as: Atensine

06

What researchers measure

Primary outcomes

  1. Intraocular Pressure (IOP)

    Time frame: Within 10 minutes before the surgery procedure

07

Results

Posted Aug 25, 2020

Participant flow

Participant flow — Overall Study
MilestoneSub-Tenon's Group ControlSub-Tenon's Group ClonidinePeribulbar Group ControlPeribulbar Group Clonidine
Started20202020
Completed20202020
Not completed0000

Outcome measures

PrimaryIntraocular Pressure (IOP)
Time frame:
Within 10 minutes before the surgery procedure
Reported as:
Mean · mmHg
Intraocular Pressure (IOP)
mmHgSub-Tenon's Group ControlSub-Tenon's Group ClonidinePeribulbar Group ControlPeribulbar Group Clonidine
Intraocular Pressure (IOP)18 ± 316 ± 419 ± 316 ± 4

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Sub-Tenon's Group Control—0/20 (0%)0/20 (0%)
Sub-Tenon's Group Clonidine—0/20 (0%)0/20 (0%)
Peribulbar Group Control—0/20 (0%)0/20 (0%)
Peribulbar Group Clonidine—0/20 (0%)0/20 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Sub-Tenon's Group ControlSub-Tenon's Group ClonidinePeribulbar Group ControlPeribulbar Group ClonidineTotal
Mean62 ± 1260 ± 1364 ± 1462 ± 1263 ± 13
Sex: Female, Male
Sex: Female, Male(Participants)Sub-Tenon's Group ControlSub-Tenon's Group ClonidinePeribulbar Group ControlPeribulbar Group ClonidineTotal
Female1312141251
Male786829
08

Study locations

No study locations are listed for this record.

09

References and documents

Publications

  • Pianka P, Weintraub-Padova H, Lazar M, Geyer O. Effect of sub-Tenon's and peribulbar anesthesia on intraocular pressure and ocular pulse amplitude. J Cataract Refract Surg. 2001 Aug;27(8):1221-6. doi: 10.1016/s0886-3350(01)00797-0. PubMed 11524193 ↗
  • Watkins R, Beigi B, Yates M, Chang B, Linardos E. Intraocular pressure and pulsatile ocular blood flow after retrobulbar and peribulbar anaesthesia. Br J Ophthalmol. 2001 Jul;85(7):796-8. doi: 10.1136/bjo.85.7.796. PubMed 11423451 ↗
  • Cabral SA, Carraretto AR, Brocco MC, Abreu Baptista JF, Gomez RS. Effect of clonidine added to lidocaine for sub-Tenon's (episcleral) anesthesia in cataract surgery. J Anesth. 2014 Feb;28(1):70-5. doi: 10.1007/s00540-013-1660-2. PubMed 23797624 ↗

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 25, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02733757
Lead sponsor
Federal University of Minas Gerais
Collaborators
Federal University of Espirito Santo
Responsible party
Renato Santiago Gomez (Head of surgery department of the medical school of the Federal University of Minas Gerais, Federal University of Minas Gerais) — Principal investigator
First posted
Apr 11, 2016
Start date
May 2013
Primary completion
Oct 2015
Completion
Dec 2015
Results posted
Aug 25, 2020
Last update
Aug 25, 2020

Study contacts

Sigmar Cabral, PhD
principal investigator · Federal University of Espírito Santo, Vitória
Renato Gomez, PhD
study director · Federal University of Minas Gerais, Belo Horizonte

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion